Pharmacovigilance and Drug Safety Software Market Size to touch USD 294.6 Million by 2027
The report analyzes and forecasts the Pharmacovigilance and Drug Safety Software Market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2022 to 2030. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global Pharmacovigilance and Drug Safety Software Market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view of the Pharmacovigilance and Drug Safety Software Market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report provides size (in terms of volume and value) of Pharmacovigilance and Drug Safety Software Market for the base year 2020 and the forecast between 2021 and 2028. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
Download Sample Report Copy From Here:https://www.acumenresearchandconsulting.com/request-sample/2546
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report. Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding. Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.
Market Players as below:
The market is competitive in nature owing to presence of prominent healthcare functionality companies. These prominent players involved in pharmacovigilance and drug safety software market are ArisGlobal, Ennov, EXTEDO, Online Business Applications, Inc., Oracle Corporation, Sarjen Systems Pvt. Ltd, Sparta Systems, Inc., United BioSource LLC, and among others
The major market segments of Pharmacovigilance and Drug Safety Software Market are as below:
Market By Functionality
Adverse Event Reporting Software
Drug Safety Audits Software
Issue Tracking Software
Fully Integrated Software
Market By Delivery Mode
On-premise Delivery Mode
On-demand/Cloud based (SaaS) Delivery Mode
Market By End User
Pharma and Biotech Companies
Contract Research Organizations (CROs)
Business Process Outsourcing (BPO) Firms
Other Pharmacovigilance Service Providers
Ask Query Here: richard@acumenresearchandconsulting.com or sales@acumenresearchandconsulting.com
Table Of Contents:
CHAPTER 1. Industry Overview of Pharmacovigilance and Drug Safety Software
1.1. Definition and Scope
1.1.1. Definition of Pharmacovigilance and Drug Safety Software
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Pharmacovigilance and Drug Safety Software Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Pharmacovigilance and Drug Safety Software Market By Functionality
1.2.3. Pharmacovigilance and Drug Safety Software Market By Delivery Mode
1.2.4. Pharmacovigilance and Drug Safety Software Market By End User
1.2.5. Pharmacovigilance and Drug Safety Software Market by Regions
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restrain 1
3.2.2. Restrain 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Pharmacovigilance and Drug Safety Software Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Pharmacovigilance and Drug Safety Software Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2019
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2019
4.2. R&D Status and Application Source of Pharmacovigilance and Drug Safety Software Major Manufacturers in 2019
CHAPTER 5. Pharmacovigilance and Drug Safety Software Market By Functionality
5.1. Introduction
5.2. Pharmacovigilance and Drug Safety Software Revenue By Functionality
5.2.1. Pharmacovigilance and Drug Safety Software Revenue (US$ Mn) and Forecast, By Functionality, 2016-2027
5.2.2. Adverse Event Reporting Software
5.2.2.1. Adverse Event Reporting Software Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3. Drug Safety Audits Software
5.2.3.1. Drug Safety Audits Software Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.4. Issue Tracking Software
5.2.4.1. Issue Tracking Software Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.5. Fully Integrated Software
5.2.5.1. Fully Integrated Software Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 6. Pharmacovigilance and Drug Safety Software Market Revenue By Delivery Mode
6.1. Introduction
6.2. Pharmacovigilance and Drug Safety Software Revenue (US$ Mn) By Delivery Mode
6.2.1. Pharmacovigilance and Drug Safety Software Revenue (US$ Mn) and Forecast By Delivery Mode, 2016 – 2027
6.2.2. On-premise Delivery Mode
6.2.2.1. On-premise Delivery Mode Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.3. On-demand/Cloud based (SaaS) Delivery Mode
6.2.3.1. On-demand/Cloud based (SaaS) Delivery Mode Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 7. Pharmacovigilance and Drug Safety Software Market By End User
7.1. Introduction
7.2. Pharmacovigilance and Drug Safety Software Revenue (US$ Mn) By End User
7.2.1. Pharmacovigilance and Drug Safety Software Revenue (US$ Mn) and Forecast By End User, 2016 – 2027
7.2.2. Pharma and Biotech Companies
7.2.2.1. Pharma and Biotech Companies Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.2.3. Contract Research Organizations (CROs)
7.2.3.1. Contract Research Organizations (CROs) Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.2.4. Business Process Outsourcing (BPO) Firms
7.2.4.1. Business Process Outsourcing (BPO) Firms Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.2.5. Other Pharmacovigilance Service Providers
7.2.5.1. Other Pharmacovigilance Service Providers Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 8. North America Pharmacovigilance and Drug Safety Software Market By Country
8.1. North America Pharmacovigilance and Drug Safety Software Overview
8.2. U.S.
8.2.1. U.S. Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Functionality, 2016-2027
8.2.2. U.S. Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Delivery Mode, 2016-2027
8.2.3. U.S. Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
8.3. Canada
8.3.1. Canada Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Functionality, 2016-2027
8.3.2. Canada Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Delivery Mode, 2016-2027
8.3.3. Canada Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
8.4. North America PEST Analysis
CHAPTER 9. Europe Market By Country
9.1. Europe Market Overview
9.2. U.K.
9.2.1. U.K. Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Functionality, 2016-2027
9.2.2. U.K. Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Delivery Mode, 2016-2027
9.2.3. U.K. Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
9.3. Germany
9.3.1. Germany Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Functionality, 2016-2027
9.3.2. Germany Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Delivery Mode, 2016-2027
9.3.3. Germany Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
9.4. France
9.4.1. France Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Functionality, 2016-2027
9.4.2. France Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Delivery Mode, 2016-2027
9.4.3. France Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
9.5. Spain
9.5.1. Spain Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Functionality, 2016-2027
9.5.2. Spain Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Delivery Mode, 2016-2027
9.5.3. Spain Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
9.6. Rest of Europe
9.6.1. Rest of Europe Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Functionality, 2016-2027
9.6.2. Rest of Europe Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Delivery Mode, 2016-2027
9.6.3. Rest of Europe Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
9.7. Europe PEST Analysis
CHAPTER 10. Asia Pacific Market By Country
10.1. Asia Pacific Market Overview
10.2. China
10.2.1. China Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Functionality, 2016 – 2027
10.2.2. China Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Delivery Mode, 2016 – 2027
10.2.3. China Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By End User, 2016 – 2027
10.3. Japan
10.3.1. Japan Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Functionality, 2016 – 2027
10.3.2. Japan Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Delivery Mode, 2016 – 2027
10.3.3. Japan Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By End User, 2016 – 2027
10.4. India
10.4.1. India Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Functionality, 2016 – 2027
10.4.2. India Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Delivery Mode, 2016 – 2027
10.4.3. India Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By End User, 2016 – 2027
10.5. Australia
10.5.1. Australia Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Functionality, 2016 – 2027
10.5.2. Australia Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Delivery Mode, 2016 – 2027
10.5.3. Australia Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By End User, 2016 – 2027
10.6. South Korea
10.6.1. South Korea Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Functionality, 2016 – 2027
10.6.2. South Korea Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Delivery Mode, 2016 – 2027
10.6.3. South Korea Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By End User, 2016 – 2027
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Functionality, 2016 – 2027
10.7.2. Rest of Asia-Pacific Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Delivery Mode, 2016 – 2027
10.7.3. Rest of Asia-Pacific Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By End User, 2016 – 2027
10.8. Asia Pacific PEST Analysis
CHAPTER 11. Latin America Market By Country
11.1. Latin America Market Overview
11.2. Brazil
11.2.1. Brazil Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Functionality, 2016 – 2027
11.2.2. Brazil Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Delivery Mode, 2016 – 2027
11.2.3. Brazil Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By End User, 2016 – 2027
11.3. Mexico
11.3.1. Mexico Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Functionality, 2016 – 2027
11.3.2. Mexico Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Delivery Mode, 2016 – 2027
11.3.3. Mexico Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By End User, 2016 – 2027
11.4. Rest of Latin America
11.4.1. Rest of Latin America Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Functionality, 2016 – 2027
11.4.2. Rest of Latin America Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Delivery Mode, 2016 – 2027
11.4.3. Rest of Latin America Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By End User, 2016 – 2027
11.5. Latin America PEST Analysis
CHAPTER 12. Middle East & Africa Market By Country
12.1. Middle East & Africa Market Overview
12.2. Saudi Arabia
12.2.1. Saudi Arabia Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Functionality, 2016 – 2027
12.2.2. Saudi Arabia Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Delivery Mode, 2016 – 2027
12.2.3. Saudi Arabia Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By End User, 2016 – 2027
12.3. UAE
12.3.1. UAE Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Functionality, 2016 – 2027
12.3.2. UAE Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Delivery Mode, 2016 – 2027
12.3.3. UAE Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By End User, 2016 – 2027
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Functionality, 2016 – 2027
12.4.2. Rest of Middle East & Africa Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By Delivery Mode, 2016 – 2027
12.4.3. Rest of Middle East & Africa Pharmacovigilance and Drug Safety Software Market Revenue (US$ Mn) and Forecast By End User, 2016 – 2027
12.5. Middle East & Africa PEST Analysis
CHAPTER 13. Player Analysis Of Pharmacovigilance and Drug Safety Software
13.1. Pharmacovigilance and Drug Safety Software Market Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
13.2.2. New Product Launches and Product Enhancements
13.2.3. Mergers And Acquisition In Global Pharmacovigilance and Drug Safety Software Market
13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 14. COMPANY PROFILE
14.1. ArisGlobal
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (US$ Mn), 2019
14.1.3.2. ArisGlobal 2019 Pharmacovigilance and Drug Safety Software Business Regional Distribution
14.1.4. Product/ Service and Specification
14.1.5. Recent Developments & Business Strategy
14.1.6. Manufacturing Plant Footprint Analysis
14.2. Ennov
14.3. EXTEDO
14.4. Online Business Applications, Inc.
14.5. Oracle Corporation
14.6. Sarjen Systems Pvt. Ltd
14.7. Sparta Systems, Inc.
14.8. United BioSource LLC
14.9. Others
To Get Premium Report Full Copy in Form of Single user or Multiple user@https://www.acumenresearchandconsulting.com/buy-now/0/2546
About Us:
Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.
